secwatch.observer — SEC 8-K summary
======================================

Issuer:     CDT Equity Inc. (CDT)
CIK:        0001896212
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001641172-25-023840
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

CDT Equity restates Q1 2025 financials; $0.4M milestone misclassified as R&D
----------------------------------------------------------------------------

- On Aug 8, 2025, CDT Equity determined its unaudited Q1 2025 financials should no longer be relied upon.
- $0.4 million in milestone payments to Sarborg Limited were misclassified as R&D expense instead of an acquired diagnostic asset.
- The restatement requires amendments to the Q1 2025 10-Q, affecting balance sheet, income statement, and cash flows.
- The Audit Committee and independent accounting firm CBIZ CPAs agreed on the restatement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1896212/000164117225023840/0001641172-25-023840-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1896212/000164117225023840/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-023840

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer